CTCF generally only binds non-methylated DNA sequences (39–42), so cancer-related methylation changes can impact genomic architecture broadly or at specific loci, although in some sites CTCF binding remains independent of DNA methylation suggesting that methylation may be one of many synergistic factors impacting transcription factor binding (43). The gene discussed is CTCF; the disease is cancer.